European Medicines Agency Recommends Granting Marketing Authorisation for Cinacalcet Mylan

Yes

It is intended for the reduction of hypercalcaemia in patients with parathyroid carcinoma

No relation
No
09/10/2015 1:37 pm
There are no related objects.